Background Mesenchymal stem cell (MSC) transplantation has been reported to improve
neurological function following neural injury. Many physiological and molecular …

Ischemic brain injury is associated with a high rate of mortality and disability with no effective
therapeutic strategy. Recently, a growing number of studies are focusing on mesenchymal …

Adult bone marrow-derived mesenchymal stem cells (MSCs) display a spectrum of
functional properties. Transplantation of these cells improves clinical outcome in models of …

Ischemic brain injury represents a major cause of death worldwide with limited treatment
options with a narrow therapeutic window. Accordingly, novel treatments that extend the …

Developing effective therapies for serious neurological insults remains a major challenge for
biomedical research. Despite intense efforts, the ability to promote functional recovery after …

Bone marrow-derived mesenchymal stem cells (MSCs) have great potential as therapeutic
agents in stroke management, since they are easily accessible and can be rapidly …

Stroke is a major disease that leads to high mortality and morbidity. Given the ageing
population and the potential risk factors, the prevalence of stroke and socioeconomic burden …

Traumatic brain injury (TBI) is characterized by a disruption in the normal function of the
brain due to an injury following a trauma, which can potentially cause severe physical …

Traumatic brain injury (TBI) is a major cause of injury-related mortality and morbidity in the
USA and around the world. The survivors may suffer from cognitive and memory deficits …

Therapy with mesenchymal stem cells (MSCs) has showed to be promising due to its
immunomodulatory function. Traumatic brain injury (TBI) triggers immune response and …